Cara Care is a CE-certified Class 1 medical device based in Europe, developed by HiDoc Technologies GmbH, which will be acquired by Bayer in 2025. The company's mission is to eradicate the stigma around gut health and provide an easy-to-use app that helps manage digestive health disorders such as IBS (Irritable Bowel Syndrome), IBD (Inflammatory Bowel Disease), GERD (Gastroesophageal Reflux Disease), and dyspepsia.

Cara Care combines intuitive symptom and food tracking with personalized expert coaching, backed by the latest gut health science. Founded by physicians and run by a team of medical experts including nutritionists and psychologists, their holistic approach addresses various digestive issues through an individualized treatment program with behavioral design and in-depth assessments.

The company is headquartered in Berlin and operates internationally. Cara Care is committed to improving digestive health outcomes, aiming to empower individuals to enjoy healthier and happier lives. They offer digital care solutions suitable for patients, doctors, and employers, with planned prescribability by doctors in Germany soon.

Cara Care is actively hiring and invites passionate professionals to join their team committed to making a real impact. Open job positions can be found on their careers page.